EVERFILL
LIVE

Serial Number

88219381

Owner

Everfill Oy

Attorney

Geza C. Ziegler Jr.

Filing Date

Dec 6, 2018

Add to watchlist:

No watchlists yet
View on USPTO

EVERFILL Trademark

Serial Number: 88219381 • Registration: 6285602

EVERFILL is a trademark filed by Everfill Oy on December 6, 2018. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Everfill Oy

c/o S Yritysjuridiikka Oy
Helsinki 00120 , FI

Entity Type: 99

Trademark Details

Filing Date

December 6, 2018

Registration Date

March 9, 2021

Published for Opposition

December 22, 2020

Goods & Services

Cell-free tissue preparations, namely, human and animal adipose tissue extracts for regeneration of skin and and subcutaneous tissue for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Biological tissue for implantation, namely, biological skin tissue intended for subsequent implantation; Skin grafts; Biological tissue cultures for medical purposes; Human allograft tissue; Pharmaceutical and medicinal preparations, namely, pharmaceutical and medicinal extracts in the nature of human and animal adipose tissue extracts for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Synergists and adjuvants for living tissues for medical purposes; Synergists and adjuvants for live organs and tissues for medical surgical purposes; Processed human donor skin for the replacement of soft tissue; Medicinal healthcare preparations in the nature of human and animal adipose tissue extract for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Pharmaceutical preparations for treating skin disorders; Skin care preparations for medical use; Pharmaceutical preparations for use in tissue transplantation, specifically, for regeneration of skin; Pharmaceutical preparations for the regeneration of tissue; Adhesive bandages for skin wounds; Medical dressings; Pharmaceuticals and natural remedies all in the nature of human and animal adipose tissue extracts for regeneration of tissue for subsequent implantation, subcutaneous injection, application on intact or injured skin, application on wound bed, and intra-articular injection; Preparations for cleansing the skin for medical use; Adhesive skin patches for medical use, namely, medicinal patches for the treatment of skin defects; Medicated skin care preparations

Human healthcare; Medical services; Dermatological services for treating skin conditions; Medical services for treatment of the skin; Medical services for the care of the skin; Medical diagnostic reporting, monitoring, advice, consultancy, and information relating to any of the aforesaid services

Medical equipment and accessory equipment, namely, medical devices for the treatment of skin defects, specifically, hydrogels; Artificial skin replacing membranes, namely, artificial skin for replacing blemished, scarred, disfigured or unhealthy skin in order to treat skin defects; Sutures; Wound closing materials and products, namely, medical devices for closing wounds; Artificial skin implants; Transplant sutures for use in surgery; none of the abovementioned products being related to extracorporeal blood treatment and renal insufficiency; Medical applicators, namely, injection syringes, injection needles and catheters

Non-medicated cosmetic preparations, namely, non-medicated cosmetic preparations formed from extracts derived from human and animal tissue sold as components of cosmetics; Non-medicated cosmetics

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 9, 2026 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 18, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 18, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 18, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 9, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 22, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 22, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 2, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 16, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 16, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 16, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 13, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 13, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 13, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 1, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 30, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 30, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 27, 2019 GNRN
NON-FINAL ACTION E-MAILED
Sep 27, 2019 GNRT
NON-FINAL ACTION WRITTEN
Sep 27, 2019 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 13, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 13, 2019 CRFA
ASSIGNED TO LIE
Sep 11, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 5, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2019 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2019 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 6, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 28, 2018 NWOS
NEW APPLICATION ENTERED
Dec 10, 2018 NWAP